KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Amortizatization of Intangibles (2024 - 2025)

Historic Amortizatization of Intangibles for Nektar Therapeutics (NKTR) over the last 2 years, with Q3 2025 value amounting to -$1.4 million.

  • Nektar Therapeutics' Amortizatization of Intangibles rose 3057.17% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year change of. This contributed to the annual value of -$9.2 million for FY2024, which is 3776.93% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Amortizatization of Intangibles of -$1.4 million as of Q3 2025, which was up 3057.17% from -$869000.0 recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Amortizatization of Intangibles peaked at -$869000.0 during Q2 2025, and registered a low of -$3.1 million during Q1 2024.